Ablynx NV
DelistedCIK 1617582fmd_1Y1E99A2XGTQC7ZRZG9EG8PGXZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 3 periods
| Line item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| Total revenues | 78 | 85 | 56 |
| Research and development | 83 | 100 | 91 |
| Operating income | (17) | (29) | (54) |
| Interest expense | 39 | 7 | 55 |
| Income before taxes | (55) | (1) | (109) |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (55) | (1) | (109) |
| Net income | (55) | (1) | (109) |